Active Shortage

MYLAN-ALMOTRIPTAN

MYLAN PHARMACEUTICALS ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MYLAN-ALMOTRIPTAN in Canada?

Yes. MYLAN-ALMOTRIPTAN 12.5MG has an active shortage reported to Health Canada (last updated September 29, 2026).

Why is MYLAN-ALMOTRIPTAN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MYLAN-ALMOTRIPTAN be available again?

The manufacturer's estimated resolution date is February 9, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products

Expected resolution~3 months remaining (estimate)

Affected strength12.5MG

Report last updated2026-09-29

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

SANDOZ ALMOTRIPTAN

SANDOZ CANADA INCORPORATED

12.5MG · DIN 02405334

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ALMOTRIPTAN

PRO DOC LIMITEE

12.5MG · DIN 02424029

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

MYLAN-ALMOTRIPTAN

MYLAN PHARMACEUTICALS ULC

6.25MG · DIN 02398435

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-02-09

~3 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02398443

Strength

12.5MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ALMOTRIPTAN

Tier

Unrated

Last Updated

2026-09-29

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

MYLAN-ALMOTRIPTAN has 3 shortage/discontinuation reports on file — this is one of them.

2026-09-29

Active Shortage

Disruption of the manufacture of the drug.

2026-09-23

Resolved

Disruption of the manufacture of the drug.

Other Products from MYLAN PHARMACEUTICALS ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AZITHROMYCIN FOR INJECTION, USP

500MG · DIN 02385473

333MG · DIN 02293269

40MG · DIN 02257963

10MG · DIN 02257955

DIN 02388138

DIN 02388146